The use of biomaterials in islet transplantation

Current Diabetes Reports

Volumn 11, Issue 5, 2011, Pages 434-444

  Borg, Danielle J ^a   Bonifacio, Ezio ^a  

^a CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

Biomaterial; Encapsulation; Islet niche; Islet transplantation; Type 1 diabetes

Indexed keywords

3 HYDROXYBUTYRIC ACID; BIOMATERIAL; BIOPOLYMER; HEPARIN; HYDROXYHEXANOATE; KALININ; MACROGOL; POLY(N ISOPROPYLACRYLAMIDE); POLYDIOXANONE; POLYESTER; POLYGLACTIN; POLYHYDROXYALKANOIC ACID; POLYLACTIC ACID; POLYVINYL ALCOHOL; SCLEROPROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ACCESSORY CELL; BONE MARROW CELL; CELL ENCAPSULATION; ENDOTHELIUM CELL; HUMAN; HYDROGEL; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MESENCHYMAL STEM CELL; MICROENCAPSULATION; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET TRANSPLANTATION; PORTAL VEIN; PROTECTION; PROTEIN EXPRESSION; REVIEW;

BIOCOMPATIBLE MATERIALS; CAPSULES; DIABETES MELLITUS, TYPE 1; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; ISLETS OF LANGERHANS TRANSPLANTATION;

EID: 80755133577     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-011-0210-2     Document Type: Review

References (98)

1. Merani S, Shapiro AMJ. Current status of pancreatic islet transplantation. Clin Sci (Colch). 2006;110:611-25. (Pubitemid 43844731)
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med. 1993;329:977-86.
3. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2002;25 suppl 1:s5-s20.
4. Jansson L, Carlsson PO. Graft vascular function after transplantation of pancreatic islets. Diabetologia. 2002;45(6):749-63.
5. Desai N, Goss J, Deng S, et al. Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation. 2003;76(1):1623-5. (Pubitemid 37549837)
6. Zahr E, Molano R, Pileggi A, et al. Rapamycin impairs in vivo proliferation of islet beta-cells. Transplantation. 2007;84(12): 1576-83.
7. Zhang N, Su D, Qu S, et al. Sirolimus is associated with reduced islet engraftment and impaired cell function. Diabetes. 2006; 55(9):2429-36. (Pubitemid 44871142)
8. Cantaluppi V, Biancone L, RomanazziGM, et al. Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: relevance for islet transplantation. Am J Transplant. 2006;6 (11):2601-11. (Pubitemid 44571680)
9. Lanza RP, Hayes JL, Chick WL. Encapsulated cell technology. Nature. 1996;14:1107-11. (Pubitemid 26299109)
10. de Vos P, Faas MM, Strand B, et al. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials. 2006;27 (32):5603-17. (Pubitemid 44177795)
11. Teramura Y, Iwata H. Bioartificial pancreas- microencapsulation and conformal coating of islet of langerhans. Adv Drug Deliv Rev. 2010;62(7-8):827-40.
12. Eberhard D, Lammert E. The pancreatic cell in the islet and organ community. Curr Opin Genet Dev. 2009;19(5):469-75.
13. Nikolova G, Jabs N, Konstantinova I, et al. The vascular basement membrane: a niche for insulin gene expression and cell proliferation. Dev Cell. 2006;10(3):397-405.
14. Nikolova G, Strilic B, Lammert E. The vascular niche and its basement membrane. Trends Cell Biol. 2007;17(1):19-25. (Pubitemid 46027587)
15. Otonkoski T, Banerjee M, Korsgren O, et al. Unique basement membrane structure of human pancreatic islets: implications for cell growth and differentiation. Diabetes Obes Metabol. 2008;10:119-27.
16. Virtanen I, Banerjee M, Palgi J, et al. Blood vessels of human islets of langerhans are surrounded by a double basement membrane. Diabetologia. 2008;51(7):1181-91.
17. Wojtusciszyn A, Armanet M, Morel P, et al. Insulin secretion from human beta cells is heterogeneous and dependent on cell-to-cell contacts. Diabetologia. 2008;51(10):1843-52.
18. Gautam D, Han S-J, Hamdan FF, et al. A critical role for ? cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metabol. 2006;3(6):449-61. (Pubitemid 43811775)
19. Unger RH, Orci L. Paracrinology of islets and the paracrinopathy of diabetes. Proc Natl Acad Sci U S A. 2010;107(37):16009-12.
20. Huypens P, Ling Z, Pipeleers D, et al. Glucagon receptors on human islet cells contribute to glucose competence of insulin release. Diabetologia. 2000;43(8):1012-101.
21. Bosco D, Armanet P, Morel P, et al. Unique arrangement of alpha cells and beta cells in human islets of Langerhans. Diabetes. 2010;59(5):1202-10.
22. Ahrén B. Autonomic regulation of islet hormone secretion-implications for health and disease. Diabetologia. 2000;43(4):393-410. (Pubitemid 30237947)
23. Drucker DJ. The role of gut hormones in glucose homeostasis. J Clin Investig. 2007;117(1):24-32. (Pubitemid 46048446)
24. Wang RN, Rosenberg L. Maintenance of beta-cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship. J Endocrinol. 1999;163:181-90.
25. Vajkoczy P, Olofsson AM, Lehr HA, et al. Histogenesis and ultrastructure of pancreatic islet graft microvasculature. Evidence for graft revascularization by endothelial cells of host origin. Am J Pathol. 1995;146(6):1397-405.
26. Menger MD, Vajkoczy P, Leiderer R, et al. Influence of experimental hyperglycemia on microvascular blood perfusion of pancreatic islet isografts. J Clin Investig. 1992;90(4):1361-9.
27. Hirshberg B. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression. J Clin Endocrinol Metab. 2002;87(12):5424-9. (Pubitemid 36034338)
28. Vasir B, Aiello LP, Yoon KH, et al. Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes. 1998;47(12):1894-903. (Pubitemid 28549196)
29. Lai Y, Schneider D, Kidszun A, et al. Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation. 2005;79(11):1530-6. (Pubitemid 40847584)
30. Brissova M, Shostak A, Shiota M, et al. Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes. 2006;55(11):2974-85. (Pubitemid 44923633)
31. Bosco D, Meda P, Halban PA, et al. Importance of cell-matrix interactions in rat islet beta-cell secretion in vitro: role of alpha6beta1 integrin. Diabetes. 2000;49(2):233-43. (Pubitemid 30071002)
32. Hammar E, Parnaud G, Bosco D, et al. Extracellular matrix protects pancreatic ?-cells against apoptosis. Diabetes. 2004;53 (8):2034-41.
33. Parnaud G, Hammar E, Ribaux P, et al. Signaling pathways implicated in the stimulation of beta-cell proliferation by extracellular matrix. Mol Endocrinol. 2009;23(8):1264-71.
34. Contreras J. Peripheral mobilization of recipient bone marrowderived endothelial progenitor cells enhances pancreatic islet revascularization and engraftment after intraportal transplantation. Surgery. 2003;134(2):390-8. (Pubitemid 37070366)
35. Nyqvist D, Köhler M, Wahlstedt H, et al. Donor islet endothelial cells participate in formation of functional vessels within pancreatic islet grafts. Diabetes. 2005;54(8):2287-93. (Pubitemid 41134254)
36. Miller R, Cirulli V, Diaferia GR, et al. Switching-on survival and repair response programs in islet transplants by bone marrow-derived vasculogenic cells. Diabetes. 2008;57(9): 2402-12.
37. Johansson U, Elgue G, Nilsson B, et al. Composite isletendothelial cell grafts: a novel approach to counteract innate immunity in islet transplantation. Am J Transplant. 2005;5 (11):2632-9.
38. Ianus A. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Investig. 2003;111(6):843-50. (Pubitemid 37074959)
39. Hess D, Li L, Martin M, et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol. 2003;21(7):763-70. (Pubitemid 36791394)
40. Sordi V, Piemonti L. The contribution of hematopoietic stem cells to beta-cell replacement. Curr Diabetes Rep. 2009;9 (2):119-24.
41. Sordi V, Malosio ML, Marchesi F, et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood. 2005;106(2):419-27. (Pubitemid 40981232)
42. Lee RH, Seo MJ, Reger RL, et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A. 2006;103(46):17438-43. (Pubitemid 44788987)
43. Ezquer F, Ezquer M, Parrau D, et al. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant. 2008;14(6):631-40.
44. Figliuzzi M, Cornolti R, Perico N, et al. Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats. Transplant Proc. 2009;41(5):1797-800.
45. Park KS, Kim YS, Kim JH, et al. Influence of human allogenic bone marrow and cord blood-derived mesenchymal stem cell secreting trophic factors on ATP (adenosine-5?-triphosphate)/ADP (adenosine-5?-diphosphate) ratio and insulin secretory function of isolated human islets from cadaveric donor. Transplant Proc. 2009;41(9):3813-8.
46. Lu Y, Jin X, Chen Y, et al. Mesenchymal stem cells protect islets from hypoxia/reoxygenation-induced injury. Cell Biochem Funct. 2010;28(8):637-43.
47. Jacobson S, Kumagai-Braesch M, Tibell A, et al. Co-transplantation of stromal cells interferes with the rejection of allogeneic islet grafts. Ann N YAcad Sci. 2008;1150(1):213-6.
48. Ding Y, Xu D, Feng G, et al. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and ?9. Diabetes. 2009;58 (8):1797-806.
49. Madec AM, Mallone R, Afonso G, et al. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia. 2009;52(7):1391-9.
50. Berman DM, Willman MA, Han D, et al. Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates. Diabetes. 2010;59(10):2558-68.
51. Capila I, Linhardt RJ. Heparin-protein interactions. Angew Chem Int Ed. 2002;41:390-412.
52. Cabric S, Sanchez J, Lundgren T, et al. Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes. 2007;56(8):2008-15. (Pubitemid 47195827)
53. Cabric S, Sanchez J, Johansson U, et al. Anchoring of vascular endothelial growth factor to surface-immobilized heparin on pancreatic islets: implications for stimulating islet angiogenesis. Tissue Eng Part A. 2010;16(3):961-70. This paper showed the immobiliziation of heparin and VEGF-A to islets allowing adhesion of endothelial cells and unaffected insulin release.
54. Rajangam K, Behanna HA, Hui MJ, et al. Heparin binding nanostructures to promote growth of blood vessels. Nano Lett. 2006;6(9):2086-90. (Pubitemid 44555259)
55. Stendahl JC, Wang L-J, Chow LW, et al. Growth factor delivery from self-assembling nanofibers to facilitate islet transplantation. Transplantation. 2008;86(3):478-81.
56. Chow LW, Wang L-J, Kaufman DB, et al. Self-assembling nanostructures to deliver angiogenic factors to pancreatic islets. Biomaterials. 2010;31(24):6154-61.
57. Freudenberg U, Hermann A, Welzel PB, et al. A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases. Biomaterials. 2009;30(28):5049-60.
58. Sodergard A, Stolt M. Properties of lactic acid based polymers and their correlation with composition. Prog Polym Sci. 2002;27:1123-63. (Pubitemid 34614061)
59. Dufour JM, Rajotte RV, Zimmerman M, et al. Development of an ectopic site for islet transplantation, using biodegradable scaffolds. Tissue Eng. 2005;11(9/10):1323-31. (Pubitemid 41636419)
60. Blomeier H, Zhang X, Rives C, et al. Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation. Transplantation. 2006;82(4):452-9. (Pubitemid 44290249)
61. Kin T, O'Neil JJ, Pawlick R, et al. The use of an approved biodegradable polymer scaffold as a solid support system for improvement of islet engraftment. Artif Organs. 2008;32(12):990-93. Using a Food and Drug-approved synthetic absorable implant laden with autogenic islets, the authors show the improvement in glycemia of pancreatectomized dogs.
62. Yang X-D, Li H-M, ChenM, et al. Enhanced insulin production from murine islet beta cells incubated on poly(3-hydroxybutyrate-co-3- hydroxyhexanoate). J Biomed Mater Res. 2009;92A(2):548-55.
63. Kloxin AM, Kloxin CJ, Bowman CN, et al. Mechanical properties of cellularly responsive hydrogels and their experimental determination. Adv Mater. 2010;22(31):3484-94.
64. Ito M, Taguchi T. Enhanced insulin secretion of physically crosslinked pancreatic ?-cells by using a poly(ethylene glycol) derivative with oleyl groups. Acta Biomater. 2009;5(8):2945-52.
65. Totani T, Teramura Y, Iwata H. Immobilization of urokinase on the islet surface by amphiphilic poly(vinyl alcohol) that carries alkyl side chains. Biomaterials. 2008;29(19):2878-83.
66. Shimizu H, Ohashi K, Utoh R, et al. Bioengineering of a functional sheet of islet cells for the treatment of diabetes mellitus. Biomaterials. 2009;30(30):5943-9.
67. Williams SJ, Wang Q, MacGregor RR, et al. Adhesion of pancreatic beta cells to biopolymer films. Biopolymers. 2009;91 (8):676-85.
68. Mei Y, Hollister-Lock J, Bogatyrev SR, et al. A high throughput micro-array system of polymer surfaces for the manipulation of primary pancreatic islet cells. Biomaterials. 2010;31(34):8989-95. An elegant high-throughput system is reported to study polymer surfaces for islet cell attachment.
69. Scharp DW, Mason NS, Sparks RE. Islet immuno-isolation: the use of hybrid artificial organs to prevent islet tissue rejection. World J Surg. 1984;8:221-9. (Pubitemid 15019206)
70. Scharp DW, Swanson CJ, Olack BJ, et al. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes. 1994;43(9):1167-70. (Pubitemid 24265481)
71. Clark H, Barbari TA, Stump K, et al. Histologic evaluation of the inflammatory response around implanted hollow fiber membranes. J Biomed Mater Res. 2000;52:183-92. (Pubitemid 30490996)
72. Dulong JL, Legallais C, Darquy S, et al. A novel model of solute transport in a hollow-fiber bioartifical pancreas based on a finite element method. Biotechnol Bioeng. 2002;78(5):576-82. (Pubitemid 34727951)
73. Kawakami Y, Iwata H, Gu Y, et al. Modified subcutaneous tissue with neovascularization is useful as the site for pancreatic islet transplantation. Cell Transplant. 2000;9(5):729-32. (Pubitemid 32002584)
74. de Vos P, de Haan BJ, Wolters GH, et al. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia. 1997;40 (3):262-70. (Pubitemid 27096549)
75. Sakurai T, Satake A, Nagata N, et al. The development of new immunoisolatory devices possessing the ability to induce neovascularization. Cell Transplant. 2003;12(5):527-35. 9. (Pubitemid 36993196)
76. Pileggi A, Molano RD, Ricordi C, et al. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation. 2006;81(9):1318-24. (Pubitemid 43804553)
77. Ludwig B, Zimerman B, Steffen A, et al. A novel device for islet transplantation providing immune protection and oxygen supply. Horm Metab Res. 2010;42(13):918-22. The authors report an extravascular device in which optimized oxygen levels are delivered to immunoprotected islets in a minipig model.
78. Chick W, Like A, Lauris V. Beta cell culture on synthetic capillaries: an artificial endocrine pancreas. Science. 1975;187 (4179):847-9.
79. Sun AM, Parisius W, Healy GM, et al. The use, in diabetic rats and monkeys, of artificial capillary units containing cultured islets of langerhans (artificial endocrine pancreas). Diabetes. 1977;26 (12):1136-9. (Pubitemid 8283434)
80. Sullivan SJ, Maki T, Borland KM, Mahoney MD, et al. Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. Science. 1991;252:718-21. (Pubitemid 21917002)
81. Maki T, Lodge JP, Carretta M, et al. Treatment of severe diabetes mellitus for more than one year using a vascularized hybrid artificial pancreas. Transplantation. 1993;55(4):713-7.
82. Maki T, Otsu I, O'Neil JJ, et al. Treatment of diabetes by xenogeneic islets without immunosuppression. Use of a vascularized bioartificial pancreas. Diabetes. 1996;42(33):342-7. (Pubitemid 26069049)
83. Cronin KJ, Messina A, Knight KR, et al. New murine model of spontaneous autologous tissue engineering, combining an arteriovenous pedicle with matrix materials. Plast Reconstr Surg. 2004;113(1):260-9. (Pubitemid 39202038)
84. Hussey AJ, Winardi M, Han XL, et al. Seeding of pancreatic islets into prevascularized tissue engineering chambers. Tissue Eng Part A. 2009;15(12):3823-33.
85. Hussey AJ, Winardi M, Wilson J, et al. Pancreatic islet transplantation using vascularised chambers containing nerve growth factor ameliorates hyperglycaemia in diabetic mice. Cells Tissues Organs. 2010;191(5):382-93.
86. Calafiore R, Luca G, Calvitti M, et al. Cellular support systems for alginate microcapsules containing islets, as composite bioartificial pancreas. Ann N YAcad Sci. 2001;944:240-51. (Pubitemid 34053310)
87. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science. 1980;210(4472):908-10. (Pubitemid 11169847)
88. Lum ZP, Tai IT, Krestow M, et al. Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes. 1991;40(11):1511-6.
89. Fan MY, Lum ZP, Fu XW, et al. Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Diabetes. 1990;39(4):519-22.
90. Calafiore R, Basta G, Luca G, et al. Alginate/polyaminoacidic coherent microcapsules for pancreatic islet graft immunoisolation in diabetic recipients. Ann N YAcad Sci. 1997;831:313-22. (Pubitemid 28045286)
91. Soon-Shiong P, Feldman E, Nelson R, et al. Long-term reversal of diabetes by injection of immunoprotected islets. Proc Natl Acad Sci U S A. 1993;90:5843-7. (Pubitemid 23176259)
92. Soon-Shiong P, Heintz RE, Merideth N, et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet. 1994;343(8903):950-1. (Pubitemid 24117231)
93. Figliuzzi M, Plati T, Cornolti R, et al. Biocompatibility and function of microencapsulated pancreatic islets. Acta Biomater. 2006;2(2):221-7. (Pubitemid 43230479)
94. Safley SA, Kapp JA,Weber CJ. Proliferative and cytokine responses in CTLA4-Ig-treated diabetic NOD mice transplanted with microencapsulated neonatal porcine ICCs. Cell Transplant. 2002;11(7):695-705. (Pubitemid 36026447)
95. Safley SA, Kapp LM, Tucker-Burden C, et al. Inhibition of cellular immune responses to encapsulated porcine islet xenografts by simultaneous blockade of two different costimulatory pathways. Transplantation. 2005;79(4):409-18. (Pubitemid 40280172)
96. Cui H, Tucker-Burden C, Cauffiel SMD, et al. Long-term metabolic control of autoimmune diabetes in spontaneously diabetic nonobese diabetic mice by nonvascularized microencapsulated adult porcine islets. Transplantation. 2009;88(2):160-9.
97. Calafiore R, Basta G, Luca G, et al. Grafts of microencapsulated pancreatic islet cells for the therapy of diabetes mellitus in nonimmunosuppressed animals. Biotechnol Appl Biochem. 2004;39 (23):159-64. (Pubitemid 38510061)
98. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005;23(1):47-55. (Pubitemid 41724624)